# NGL Fine Chem Ltd (NGLFINE)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹2501.9
Day Change: +3.81%
52W High: ₹2750
52W Low: ₹985.05
Market Cap: ₹1,450 Cr

## Valuation
P/E: 40.98
P/B: 4.83
EPS: ₹57.26
Book Value: ₹485.91
Dividend Yield: 0%

## Returns
1Y Return: 55.88%

## Profitability
ROE: 0%
ROCE: 6.29%
Debt/Equity: 0.29
Revenue Growth: 43.1%
Profit Growth: 1127.1%
EBITDA Margin: 11.86%
Operating Margin: 13.44%

## About
NGL Fine Chem Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: NGL Fine Chem Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:59:02.417Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:02.417Z
Quant Updated: 2026-05-18T22:59:02.417Z
Sentiment Updated: 2026-05-18T22:59:02.417Z
Financials Status: current
Financials Updated: 2026-05-18T18:30:47.905Z
Financials Last Attempt: 2026-05-18T18:30:47.905Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2020)
Revenue: ₹153 Cr
Operating Profit: ₹32 Cr (OPM 21%)
Net Profit: ₹20 Cr
Tax: ₹28 Cr

## Annual P&L History
Mar 2020: Rev ₹153Cr | PAT ₹20Cr | OPM 21%
Mar 2021: Rev ₹152Cr | PAT ₹8Cr | OPM 14%
Mar 2022: Rev ₹258Cr | PAT ₹57Cr | OPM 31%

## Balance Sheet (Mar 2020)
Total Assets: ₹142 Cr
Total Liabilities: ₹142 Cr
Borrowings: ₹27 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rahul Jayant Nachane ACA, B. Com, DBF, MMS, CEO, MD, Chief Ethics Counsellor & Executive Director
- Rajesh Narayan Lawande, Whole Time Director & CFO
- Ahaan  Nachane, Vice President
- Shivam  Gharat, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/nglfine
Disclaimer: For research and education only. Not investment advice.